Introduced by Senator Doyle of Washington District, Senator Leddy of Chittenden District and Senator White of Windham District
Subject: Drugs; pseudoephedrine; retail sales limits
Statement of purpose: This bill proposes to place limits on the amount of pseudoephedrine which can be sold at retail and to require retail sellers of pseudoephedrine to obtain signatures and photographic identifications from buyers.
AN ACT RELATING TO RETAIL SALES LIMITS FOR PSEUDOEPHEDRINE
It is hereby enacted by the General Assembly of the State of Vermont:
Sec. 1. FINDINGS
The General Assembly finds:
(1) Methamphetamine, a dangerous stimulant similar to cocaine, is easily abused and is a growing problem in Vermont and throughout the United States.
(2) Used in a variety of ways, methamphetamine has devastating short‑ and long-term effects such as convulsions, anxiety, violent behavior, insomnia, confusion, hallucinations, paranoia, delusions, mood disturbances, and cognitive impairments.
(3) Methamphetamine precursors are the primary ingredients used to make methamphetamine. Pseudoephedrine, one of the major methamphetamine precursors, is a drug commonly found in over-the-counter cold medicines.
(4) Methamphetamine precursors such as pseudoephedrine are cooked in laboratories to produce methamphetamine. Methamphetamine laboratories are dangerous, especially for children, because they can explode and because the chemicals linger for years.
(5) A significant amount of methamphetamine is produced by purchasing large amounts of cold tablets and cooking the pseudoephedrine they contain in methamphetamine laboratories. Limits on over-the-counter sales of products containing pseudoephedrine will reduce the amount of methamphetamine which can be made and can protect children and others from the harms caused by methamphetamine laboratories.
Sec. 2. 18 V.S.A. § 4215b is added to read:
§ 4215b. PSEUDOEPHEDRINE; RETAIL SALES LIMITS
(a) No person shall deliver in any single over-the-counter sale:
(1) more than two packages of a product the person knows to contain pseudoephedrine as its sole active ingredient;
(2) more than three packages of a product the person knows to contain pseudoephedrine as one of its active ingredients; or
(3) any product containing pseudoephedrine, unless the purchaser provides a signature and photographic proof of his or her identity.
(b) A person who violates this section shall be imprisoned not more than six months or fined not more than $500.00, or both.
(c) As used in this section, “pseudoephedrine” means pseudoephedrine and its salts, isomers, and salts of isomers.
The Vermont General Assembly
115 State Street